Skip to main content
Caplight Logo









Thalamus

Thalamus

Private
San Francisco, CaliforniaEnterprise Softwarehttps://www.thalamusgme.com/

Last Round

Series B

Jan 30, 2025

Est. Valuation

$45M

Total Funding Raised

$44.48M

Company Overview

Thalamus is a software as a service company that provides a cloud-based interview management platform for graduate medical education training programs.

Sector

Enterprise Software

Verticals

HR, Vertical SaaS, Workflow Automation, Healthcare Analytics, Medical AI

Business Model

B2B

Customer Profile

Freemium, Subscription SaaS, Data as a Service, Services & Consulting

AI Layer

Application

Keywords

GME recruitment softwaregraduate medical educationGMEinterview scheduling platformresidency recruitmentERAS integrationMedEdTechAI application screeningholistic review softwareresidency match softwareapplicant tracking systemGME data analyticsvirtual interview platformvertical SaaSpublic benefit corporationPBC

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Thalamus Comparables

Compare Thalamus with similar companies based on industry and business-model similarity.

Thalamus comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
The Tenth Nerve, LLC
79%
Druksys, LLC
79%
Liaison International
78%

Thalamus Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJan 30, 2025
Series AFeb 17, 2022
SeedDec 12, 2019

Key People

Founding team and executive leadership

Jason Reminick

Founder and CEO

Founding Team

Vlad Eidelman

Chief Product and Technology Officer

Executive Team

Thalamus Investors

Notable investors and investment history

Thalamus investors
InvestorRounds
Fresco CapitalSeed, Series B
37 AngelsSeed
LAUNCHSeed, Series B
Kapor CapitalSeed, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 7, 2025

    Monthly visitors grew 689% MoM, reaching 3.8M.

  • Jan 30, 2025

    $30M round with participation from Fresco Capital and Kapor Capital.

Thalamus Filings

Explore SEC and related filing metadata, where available.

Thalamus filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Thalamus's valuation, stock price, and market status.

Is Thalamus a public or private company?

Thalamus is a private company.

What is the current stock price of Thalamus?

Thalamus is a private company with no public stock price. No recent secondary market data is available.

How much is Thalamus worth (valuation)?

Valuation information for Thalamus is not publicly available.

Can I buy Thalamus stock?

Thalamus shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Thalamus's last funding round?

Funding round information for Thalamus is not publicly available.

Who are the main investors in Thalamus?

Investor information for Thalamus is not publicly disclosed.

Will Thalamus IPO soon?

No public IPO plans have been announced for Thalamus.

How can I track Thalamus secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Thalamus's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range57
Year Founded2013
Last FundingJan 30, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?